Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 10 | 2022 | 402 | 3.250 |
Why?
|
| Appendicitis | 4 | 2022 | 75 | 1.710 |
Why?
|
| Thoracic Injuries | 2 | 2022 | 48 | 1.510 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 38 | 1.300 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.930 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2022 | 56 | 0.930 |
Why?
|
| Internship and Residency | 2 | 2024 | 748 | 0.880 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 57 | 0.850 |
Why?
|
| Hepatoblastoma | 1 | 2023 | 8 | 0.840 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 53 | 0.830 |
Why?
|
| Rib Fractures | 1 | 2022 | 18 | 0.800 |
Why?
|
| Interviews as Topic | 1 | 2024 | 498 | 0.790 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 29 | 0.780 |
Why?
|
| Retrospective Studies | 14 | 2023 | 6192 | 0.780 |
Why?
|
| Craniocerebral Trauma | 1 | 2022 | 57 | 0.780 |
Why?
|
| Wounds, Penetrating | 1 | 2022 | 24 | 0.780 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.770 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.770 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.770 |
Why?
|
| General Surgery | 1 | 2024 | 193 | 0.770 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 30 | 0.760 |
Why?
|
| Phytotherapy | 2 | 2018 | 53 | 0.700 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 53 | 0.690 |
Why?
|
| Gastric Bypass | 1 | 2021 | 74 | 0.690 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 278 | 0.680 |
Why?
|
| Critical Illness | 1 | 2023 | 343 | 0.670 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 96 | 0.660 |
Why?
|
| Plant Extracts | 2 | 2018 | 163 | 0.650 |
Why?
|
| Patient Readmission | 1 | 2023 | 425 | 0.640 |
Why?
|
| Appendix | 1 | 2018 | 14 | 0.620 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.600 |
Why?
|
| Neuroblastoma | 1 | 2018 | 87 | 0.560 |
Why?
|
| Child | 11 | 2022 | 4380 | 0.550 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 585 | 0.550 |
Why?
|
| Ultrasonography | 1 | 2018 | 462 | 0.520 |
Why?
|
| Infant | 7 | 2023 | 1546 | 0.510 |
Why?
|
| Humans | 24 | 2024 | 60912 | 0.470 |
Why?
|
| Thoracoscopy | 2 | 2004 | 23 | 0.450 |
Why?
|
| Appendectomy | 3 | 2020 | 50 | 0.420 |
Why?
|
| Treatment Outcome | 10 | 2022 | 5347 | 0.420 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 649 | 0.410 |
Why?
|
| Hemothorax | 2 | 2022 | 10 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 1518 | 0.390 |
Why?
|
| Thoracotomy | 2 | 2022 | 46 | 0.390 |
Why?
|
| Sutures | 2 | 2016 | 33 | 0.360 |
Why?
|
| Infant, Newborn | 4 | 2022 | 1326 | 0.350 |
Why?
|
| Length of Stay | 4 | 2022 | 784 | 0.330 |
Why?
|
| Adolescent | 9 | 2021 | 6041 | 0.330 |
Why?
|
| Male | 13 | 2024 | 28424 | 0.330 |
Why?
|
| Herniorrhaphy | 2 | 2022 | 65 | 0.320 |
Why?
|
| Young Adult | 4 | 2023 | 4430 | 0.310 |
Why?
|
| Female | 14 | 2024 | 31706 | 0.290 |
Why?
|
| Laparoscopes | 1 | 2007 | 21 | 0.290 |
Why?
|
| Touch | 1 | 2007 | 28 | 0.280 |
Why?
|
| Rhodiola | 2 | 2018 | 15 | 0.270 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 125 | 0.270 |
Why?
|
| Pandemics | 2 | 2022 | 636 | 0.260 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 22 | 0.250 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 21 | 0.250 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2022 | 93 | 0.240 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.230 |
Why?
|
| Esophageal Atresia | 1 | 2004 | 10 | 0.230 |
Why?
|
| Esophagus | 1 | 2004 | 53 | 0.230 |
Why?
|
| Personnel Selection | 1 | 2024 | 50 | 0.220 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 117 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2544 | 0.220 |
Why?
|
| Massachusetts | 3 | 2023 | 2120 | 0.210 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 61 | 0.210 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 236 | 0.200 |
Why?
|
| Ligation | 1 | 2022 | 35 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2021 | 1186 | 0.200 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.190 |
Why?
|
| Laparotomy | 1 | 2022 | 46 | 0.190 |
Why?
|
| Child, Preschool | 5 | 2018 | 1880 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 319 | 0.190 |
Why?
|
| Adult | 5 | 2024 | 16211 | 0.180 |
Why?
|
| RNA, Viral | 1 | 2022 | 265 | 0.180 |
Why?
|
| Gastrectomy | 1 | 2021 | 38 | 0.180 |
Why?
|
| Lung | 1 | 2004 | 904 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2022 | 413 | 0.160 |
Why?
|
| Cytotoxins | 1 | 2018 | 12 | 0.150 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 22 | 0.150 |
Why?
|
| Random Allocation | 2 | 2016 | 199 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1039 | 0.140 |
Why?
|
| Guinea Pigs | 1 | 2016 | 104 | 0.140 |
Why?
|
| Suture Techniques | 1 | 2017 | 88 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1389 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2018 | 947 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2642 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 562 | 0.130 |
Why?
|
| Time Factors | 1 | 2023 | 3661 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 411 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2080 | 0.130 |
Why?
|
| Wound Healing | 1 | 2016 | 177 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 147 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2015 | 103 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 74 | 0.120 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2016 | 944 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2015 | 156 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2017 | 702 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 275 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 306 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5289 | 0.090 |
Why?
|
| Animals | 4 | 2016 | 19802 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 11 | 0.070 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 8 | 0.070 |
Why?
|
| Dextrans | 1 | 2007 | 45 | 0.070 |
Why?
|
| Intussusception | 1 | 2007 | 12 | 0.070 |
Why?
|
| Choristoma | 1 | 2007 | 24 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 65 | 0.070 |
Why?
|
| Stomach | 1 | 2007 | 85 | 0.070 |
Why?
|
| Spermatic Cord Torsion | 1 | 2006 | 11 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 64 | 0.070 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 79 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 39 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 322 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2006 | 534 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 142 | 0.060 |
Why?
|
| Aged | 1 | 2021 | 13873 | 0.060 |
Why?
|
| Soft Tissue Infections | 1 | 2005 | 45 | 0.060 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 90 | 0.060 |
Why?
|
| Middle Aged | 1 | 2021 | 16857 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2004 | 27 | 0.060 |
Why?
|
| Insufflation | 1 | 2004 | 10 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 161 | 0.060 |
Why?
|
| Pressure | 1 | 2004 | 76 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 105 | 0.060 |
Why?
|
| Models, Animal | 1 | 2004 | 222 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 353 | 0.050 |
Why?
|
| Fundoplication | 1 | 2002 | 19 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 29 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 408 | 0.050 |
Why?
|
| Gangrene | 1 | 2020 | 7 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 100 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1280 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 103 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2401 | 0.030 |
Why?
|
| Risk Factors | 1 | 2005 | 5158 | 0.030 |
Why?
|
| Plant Roots | 1 | 2015 | 62 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 193 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 596 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 933 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 859 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 855 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 466 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 380 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1605 | 0.020 |
Why?
|
| Bacteriuria | 1 | 2007 | 11 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 25 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 87 | 0.020 |
Why?
|
| Sheep | 1 | 2006 | 170 | 0.020 |
Why?
|
| Testis | 1 | 2006 | 139 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 609 | 0.020 |
Why?
|
| Oxygen | 1 | 2006 | 315 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 195 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 84 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 747 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 3188 | 0.010 |
Why?
|